I’m also thinking fast track approval in the UK for HIV. I think after the interim rec (plus, the UK was willing to accept EIND data per NP that is now scientifically backed by Dr. Yang’s paper) we all pretty much know it is working.
So, I’m thinking MHRA may quickly approve LL so they get first dibs on the 300,000 vials and can use it off- label for COVID, They know supply is limited. Great for them, great for us!